Find out how NAMs are influencing safety assessments and decision-making in the pharmaceutical industry ahead of 2026.
Learn how AI is transforming predictions of drug-induced liver injury and aiding drug development for safer therapeutics.
Morning Overview on MSN
New study flags powerful drug target that could transform glaucoma treatment
Glaucoma has long been treated as a plumbing problem of the eye, managed mainly by lowering pressure rather than protecting ...
A new experimental vaccine could slow down triple negative breast cancer and reduce its recurrence after treatment.
12don MSN
Exclusive-US FDA delays two drug reviews in new voucher program after safety, efficacy concerns
By Patrick Wingrove Jan 15 (Reuters) - The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results